Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

patisiran (Onpattro)

Source date not recordedAnalyse record ↗

RNAi drug to reduce TTR production made by Alnylam, approved for hATTR.

Modality
IV
Availability (US)
by prescription (very expensive), but only for hATTR for now
Biomarkers
ATTR scan
Hallmark targeted
proteostasis / ATTR tx
Kind
age slowing
Clinical trials
16 listed